Aspergillosis - 107 Studies Found

Completed : F901318 Single Ascending Dose Study in Healthy Male Volunteers
: Invasive Aspergillosis
: 2014-05-13
:
  • Drug: F901318

Completed : Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole
: Invasive Aspergillosis
: 2010-03-02
: Drug: Voriconazole Day1: voriconazole 200 mg x 2, oral administration, Day2-7: rifampin 600 mg, once a d
Recruiting : Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
: Aspergillosis
: 2014-07-01
:
  • Drug: Posaconazole 300 mg posa
Completed : Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients
: Post Lung Transplantation
: 2005-09-13
Completed : Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
:
  • Infection
  • Pulmonary Complications

: 1999-11-01
:
  • Drug: amphotericin B deoxycholate
  • Drug: vo
Recruiting : A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
: Fungal Infections
: 2013-01-30
:
  • Drug: Posaconazole Other Names
Completed : A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
:
  • Aspergillosis
  • Candidemia

: 2009-07-13
: Drug: anidulafungin and voriconazole Subjects will be admitted to the clinical research unit on Day 0. S
Completed : Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)
:
  • Aspergillosis
  • Candidiasis

: 2004-05-11
: Drug: caspofungin acetate Duration of Treatment - 7-90 days
Terminated : Aspergillus PCR Early Detection in High Risk Oncohematological Patients
: Infections
: 2012-10-30
:
  • Procedure: Aspergillus PCR technique

Suspended : Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy
:
  • Immunocompromised Patient
  • Aspergillosis